News story
Successful reclassification of Nasonex Allergy Control Nasal Spray
MHRA reclassifies Nasonex Allergy Control
Nasonex Allergy Control 0.05% Nasal Spray will soon be available to buy over the counter in pharmacies following a public consultation by the Medicines and Healthcare products Regulatory Agency (MHRA). This nasal spray is used to treat the symptoms of allergic rhinitis such as sneezing and a runny, itchy or blocked up nose which may be caused by hay fever.
Nasonex Allergy Control is a nasal spray containing an active ingredient called mometasone furoate. This is the first product containing mometasone furoate to be available without prescription. MHRA are committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do.
Updates to this page
Published 10 July 2017